Table 1 Clinical features
From: Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia
Variable | Total cohort, n = 219 |
|---|---|
Gender, n (%) | |
 Male | 121 (55%) |
 Female | 98 (45%) |
 Age (year, median, range) | 3.75 (0.05–16.25) |
 Infant, n (%) | 11 (5%) |
  ≥ 1, n (%) | 208 (95%) |
 WBC (× 109/L, median, range) | 7.85 (0.35–912.25) |
 HB (×g/L, median, range) | 82 (27–159) |
 PLT (×109/L, median, range) | 62 (3–483) |
Immunophenotype, n (%) | |
 B-ALL | 196 (89%) |
 T-ALL | 23 (11%) |
Risk stratification defined group, n = 217, n (%) | |
 Low risk | 76 (35%) |
 Intermediate risk | 84 (38%) |
 High risk | 57 (26%) |
 Cytogenetics, n (%) |  |
 Hyperdiploid | 62 (28%) |
Genetic fusion subtype, n (%) | |
 ETV6-RUNX1 | 47 (20.4%) |
 BCR-ABL1 | 7 (3.1%) |
 TCF3-PBX1 | 10 (4.5%) |
 MLL rearrangement | 11 (5%) |